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Abstract
Background: Methamphetamine (MA) abuse is a health concern among drug abuse patients in Iran.
Objectives: This study aimed at determining the prevalence of MA dependence among a group of female methadone users and
investigating the current psychological well-being, high risk sexual and criminality behaviors, and the status of receiving MA treat-
ment.
Methods: This study was a cross-sectional survey conducted in Iran. The study was conducted at 5 central female-only methadone
services in Tehran and Karaj, during years 2011 to 2013. A questionnaire was devised to collect baseline data. The general health
questionnaire-28 and the Opiate Treatment Index were used to assess psychological well-being, and criminality and high-risk sexual
behaviors.
Results: Overall, 245 females were registered at these sites. Of them, 201 females (82%) were dependent on MA while on treatment.
Duration of MA dependence was 6 years. However, only 14.3% of the participants reported lifetime MA treatment. No participant was
on MA treatment. Participants reported high rates of MA-related depression (76.4%), anxiety (68.4%), social dysfunction (41.2%), and
somatic symptoms (38.2%), respectively. Untreated MA dependence in methadone treatment was associated with engagement in
high-risk sexual behaviors (43.8%) and criminality (28.7%). Only 10% of the participants reported receiving a lifetime matrix model.
All of them reported that the Matrix model was long and it was not easily available in methadone services.
Conclusions: The study showed that the high prevalence for MA dependence and its adverse health impacts while receiving MA
treatment remained the same. Effective psychosocial treatments should be delivered for MA dependence among female methadone
users.
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1. Background
Amphetamine-type stimulants, including metham-
phetamine (MA), are the second most commonly used
illicit drugs in the world, after cannabis (1). Metham-
phetamine dependence in Iran is associated with multiple
harms (2-4). A previous study assessed the clinical course of
patients with MA-induced psychotic disorder in a 3-month
follow-up. Overall, 50 patients (7 females and 43 males)
were assessed. Forty-six patients (92%) were re-assessed at
follow-up. More than half of the patients, who relapsed
to MA use, did not adhere to the treatment again. Posi-
tive, negative, and manic symptoms were improved in ab-
stinent patients (5). In a qualitative study, 45 males (35
MA-dependent patients, 5 family members, and 5 psychi-
atrists and medical doctors) were interviewed. The results
showed the negative impacts of MA dependence on sexual
function. A dramatic increase in libido, erectile dysfunc-
tion, premature ejaculation, and losing control during sex-
ual intercourse was reported (6).
Methamphetamine dependence has increased in Iran
(7). A review from Iran indicated that MA dependence
has increased among females and opioid-dependent peo-
ple on methadone maintenance treatment (medication as-
sisted treatment). The result showed that MA and ecstasy
dependence in 2016 was < 1% in the general population,
yet this prevalence was higher in patients on methadone
(7). Another study showed that dependence on metham-
phetamine requires special treatment and rehabilitation
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programs (8).
2. Objectives
The study aimed at determining the prevalence of
MA dependence among a group of female methadone pa-
tients. The other aims were to investigate current psycho-
logical well-being, high risk sexual, criminality, and the sta-
tus of receiving MA treatment.
3. Materials andMethods
This study was a cross-sectional survey of the preva-
lence of MA dependence in central female-only methadone
services of Tehran and Karaj, Iran. All the female-only
methadone services in Tehran and Karaj were included in
this study. All of the females in these 5 methadone ser-
vices were recruited. Females were needed to be at least 17
years old and being on methadone treatment for at least
2 months. All females met the criteria of the diagnostic
and statistical manual of mental disorders, fourth edition,
third revision for MA dependence (9). There were several
exclusion criteria including reporting withdrawal symp-
toms and drug intoxication at the time of interviewing.
A questionnaire was devised to collect data. Part of the
questionnaire, included open-ended questions regarding
lifetime MA treatment and problems associated with MA
treatment. The questionnaire assessed 36 females in a 2-
week test-re-test; the reliability was a = 87%. Females were
MA-dependent and on treatment. General health question-
naire (10) and opiate treatment index (11) were used to as-
sess mental health, criminality, and high-risk sexual behav-
iors. Both questionnaires were assessed on the same fe-
males and showed high reliability (a=83% on the first one,
a=89% on the second one, respectively).
Females were informed that the study was confiden-
tial and voluntary. Participants received 8 USD for partic-
ipation. Tehran University of Medical Sciences (90-01-49-
25493) approved the study. Consent forms were obtained
from all participants. Data were analyzed using SPSS ver-
sion 23 software.
3.1. Study Procedures
An interview room was used for conducting the study
at each center. Participants were interviewed between 10th
of January 2011 and 26th of December 2013. Each individual
was invited and interviewed by a female clinical psycholo-
gist.
4. Results
Overall, 245 female methadone patients were regis-
tered at the sites. Of them, 201 females (82%) met the crite-
ria for MA dependence (9) while in treatment. Most of the
participants reported stable living conditions (63.6%). Du-
ration of MA dependence was 6 years. However, only 14.3%
of the participants reported lifetime MA treatment. No par-
ticipant was on MA treatment while in treatment (Table 1).
Table 1. Participant Characteristics (n = 201)
Characteristics Mean/Percent
Female
Mean age, y (range 19 - 62) 039 (SD 8.5)








Currently married 76 (37.8)
Currently unmarried 125 (62.2)
CurrentMA dependence (100)
Age ofMA dependence 31 (SD 5.8)
Duration ofMA dependence 6 (SD 8.2)




Matrix Model 029 (14.3)
Present MA treatment 000 (0)
Dependence on MA was accompanied with high rates
of depression (76.4%), anxiety (68.4%), social dysfunction
(41.2%), and somatic symptoms (38.2%) on the general
health questionnaire-28, respectively. Furthermore, MA
dependence was associated with engagement in high-risk
sexual behaviors (43.8%) and criminality (28.7%) on the Opi-
ate Treatment Index. Among participants, who reported
lifetime Matrix treatment, all reported that the Matrix
Model was long (100%) and it was not easily available (56%)
in methadone services (Table 2).
5. Discussion
To the best of the author’s knowledge, this brief re-
port is the first survey of the prevalence of MA dependence
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Social dysfunction 83 (41.2)
Somatic symptoms 77 (38.2)
Opiate Treatment Index
High risk sexual behaviors 87 (43.8)
Criminality 58 (28.7)
amongst 5 Iranian female-only methadone treatment ser-
vices. The report is important because it shows how
MA dependence can be associated with multiple harms,
which may negatively influence methadone outcomes.
The present report addressed MA dependence among Ira-
nian female methadone users, who have been underre-
ported (12). In this study, female patients were middle-
aged. Most of them reported stable living conditions yet
they were generally unemployed. This is consistent with
a study, which indicated that most female methadone pa-
tients were unemployed and middle aged (13).
In this study, MA dependence was associated with high
rates of MA-related depression, anxiety, social dysfunction,
and somatic symptoms. This indicated poor psychologi-
cal well-being. Furthermore, MA dependence in treatment
was associated with engagement in high-risk sexual behav-
iors and criminality. This issue demands an effective treat-
ment. Comorbidities, such as poor mental health, can re-
duce positive drug treatment outcomes (14). Further stud-
ies are suggested in this regard.
At the time of interviewing, no participant was on MA
treatment. Among participants, who reported lifetime Ma-
trix treatment, all of them reported that the matrix model
was long and it was not easily available in methadone ser-
vices. Some studies showed that the matrix model might
be used for the treatment of MA dependence (15-18). Effec-
tive psychosocial treatments should be provided.
5.1. Conclusions
The study showed the high prevalence of MA depen-
dence and its adverse health impacts while receiving MA
treatment remained constant. As MA dependence contin-
ues among female patients, it is necessary to ensure that
adequate resources are allocated to different treatment ap-
proaches, such as the Matrix Model. However, the treat-
ment is intensive and may not be cost-effective for female
patients. Methadone services should provide short psycho-
logical treatments.
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